The 4th Drug Formulation and Bioavailability 2015 is a conference that covers topics such as:
- Selecting Methodologies, Priorities, and Risks in Salt and Polymorph Screening
- The Industry`s Technical and Regulatory Path Forward for Pediatric Formulations
- Avoid Underpredicting Exposures Through Better Modeling of Enabled Formulations
- Future Trends in Drug Formulation: Agnostic Modality
- Rethinking Early-Stage Formulation Methods
- Team Leadership Styles for Advanced Formulation Development
- Novel Automated Analysis Methods for Biorelevant Dissolution
- Utilization of Formulation Design Space to Accelerate Early Clinical Development of Drug Products
The 4th Drug Formulation and Bioavailability 2015 brings together attendees with responsibilities in:
- Preclinical Development
- Pharmaceutical Development
- Preformulation
- Formulation
- Physicochemistry
- Medicinal/Analytical/Solid-State Chemistry
- Pharmacokinetics/DMPK
- Pharmaceutics/Biopharmaceutics
- Drug Discovery
- Drug Delivery
- Toxicology
- Material Science
- Chemical Engineering
- Lifecycle/Portfolio Management
- Process R&D
